No abstract available
MeSH terms
-
Coronary Restenosis / prevention & control*
-
Diabetic Angiopathies / prevention & control*
-
Disease-Free Survival
-
Drug Combinations
-
Drug Implants
-
Eptifibatide
-
Follow-Up Studies
-
Humans
-
Immunosuppressive Agents / administration & dosage*
-
Peptides / administration & dosage
-
Platelet Aggregation Inhibitors / administration & dosage*
-
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
-
Sirolimus / administration & dosage*
-
Stents*
-
Tirofiban
-
Tyrosine / administration & dosage
-
Tyrosine / analogs & derivatives
Substances
-
Drug Combinations
-
Drug Implants
-
Immunosuppressive Agents
-
Peptides
-
Platelet Aggregation Inhibitors
-
Platelet Glycoprotein GPIIb-IIIa Complex
-
Tyrosine
-
Tirofiban
-
Eptifibatide
-
Sirolimus